Literature DB >> 28501268

Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor.

Tetsuya Masada1, Toshihiro Tanaka2, Hideyuki Nishiofuku1, Yasushi Fukuoka1, Takeshi Sato1, Shota Tatsumoto1, Nagaaki Marugami1, Kimihiko Kichikawa1.   

Abstract

PURPOSE: To compare physicochemical properties of emulsions of ethiodized oil (Lipiodol; Guerbet, Villepinte, France) and epirubicin prepared using different techniques for conventional transarterial chemoembolization.
MATERIALS AND METHODS: Lipiodol was mixed with epirubicin solution (8.33 mg/mL) by using a 3-way stopcock. The following technical parameters were compared: ratio of epirubicin solution to Lipiodol (1:2 vs 1:1), number of pumping exchanges through the stopcock (20 exchanges vs 10 exchanges), pumping speed (1 s/push vs 2 s/push), and first push syringe (epirubicin solution vs Lipiodol).
RESULTS: The mean percentage of water-in-oil was 70.45 ± 1.51 in the 1:2 epirubicin-Lipiodol ratio and 16.03 ± 2.95 in the 1:1 ratio (P < .001). The first push syringe did not influence emulsion type. Median droplet sizes were significantly larger in the slower pumping speed (52.0 μm in 2 s vs 33.7 μm in 1 s; P < .001), whereas there was no significant difference in number of pumping exchanges. Droplet sizes enlarged during 30 minutes after pumping. Viscosity was lower in the 1:1 ratio and the slower pumping speed. Viscosity decreased during 30 minutes after pumping.
CONCLUSIONS: The ratio of epirubicin to Lipiodol is a significant factor to form water-in-oil emulsions with higher viscosity. The percentage of water-in-oil is limited to 70% using current pumping techniques. The pumping speed strongly influences droplet size and viscosity.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28501268     DOI: 10.1016/j.jvir.2017.03.032

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  4 in total

Review 1.  Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma.

Authors:  Anne Hulin; Jeanick Stocco; Mohamed Bouattour
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

2.  Development of pumping emulsification device with glass membrane to form ideal lipiodol emulsion in transarterial chemoembolization.

Authors:  Toshihiro Tanaka; Tetsuya Masada; Hideyuki Nishiofuku; Yasushi Fukuoka; Takeshi Sato; Shota Tatsumoto; Nagaaki Marugami; Shushi Higashi; Kimihiko Kichikawa
Journal:  Eur Radiol       Date:  2017-12-15       Impact factor: 5.315

3.  Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.

Authors:  Doyeon Kim; Jae Hwan Lee; Hyungwon Moon; Minkyu Seo; Hyounkoo Han; Hongkeun Yoo; Howon Seo; Jingu Lee; Sujung Hong; Pilhan Kim; Hak Jong Lee; Jin Wook Chung; Hyuncheol Kim
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

4.  Synergism of wt-p53 and synthetic material in local nano-TAE gene therapy of hepatoma: comparison of four systems and the possible mechanism.

Authors:  Gaopeng Li; Wenqin Kang; Mingliang Jin; Lidong Zhang; Jian Zheng; Kai Jia; Jinfeng Ma; Ting Liu; Xueyi Dang; Zhifeng Yan; Zefeng Gao; Jun Xu
Journal:  BMC Cancer       Date:  2019-11-20       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.